(S) ethyl 2-methoxy-3-(4-aminophenyl)propionate | 515861-60-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (S) ethyl 2-methoxy-3-(4-aminophenyl)propionate
• 英文别名: ethyl (2S)-3-(4-aminophenyl)-2-methoxypropanoate
• CAS: 515861-60-6
• 化学式: C₁₂H₁₇NO₃
• 分子量: 223.272
• InChiKey: CQTKHHFNFURJMA-NSHDSACASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  61.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (S) ethyl 2-methoxy-3-(4-aminophenyl)propionate 、 4-(3-methanesulfonyloxypropyl)phenylmethanesulfonate 在 四丁基溴化铵 、 potassium carbonate 作用下， 以 甲苯 为溶剂， 反应 9.0h， 以44%的产率得到ethyl (S)-2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl)propylamino}phenyl]propionic acid
  参考文献：
  名称：

  [EN] BASIC SALTS AND MONOHYDRATES OF CERTAIN ALPHA, BETA-PROPRIONIC ACID DERIVATIVE
  [FR] SELS DE BASE ET MONOHYDRATES DE CERTAINS DERIVES D'ACIDE ALPHA, BETA-PROPRIONIQUE

  摘要：

  本发明提供了(S)-2-甲氧基-3-[4-{3-(4-甲磺酰氧苯基)丙基氨基}苯基]丙酸的新型盐，包括(S)-2-甲氧基-3-[4-{3-(4-甲磺酰氧苯基)丙基氨基}苯基]丙酸精氨酸盐单水合物、(S)-2-甲氧基-3-[4-{3-(4-甲磺酰氧苯基)丙基氨基}苯基]丙酸精氨酸盐和(S)-2-甲氧基-3-[4-{3-(4-甲磺酰氧苯基)丙基氨基}苯基]丙酸单水合物。本发明还包括各种方面和实施例。本发明还提供了含有(S)-2-甲氧基-3-[4-{3-(4-甲磺酰氧苯基)丙基氨基}苯基]丙酸新型盐的组合物。

  公开号：

  WO2006001795A1
• 作为产物：
  描述：

  (S)-ethyl 2-methoxy-3-(4-nitrophenyl)propionate 在 palladium 10% on activated carbon 氢气 作用下， 以 甲醇 为溶剂， 反应 4.0h， 以100%的产率得到(S) ethyl 2-methoxy-3-(4-aminophenyl)propionate
  参考文献：
  名称：

  Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them

  摘要：

  本发明涉及具有化学式（I）的新型抗糖尿病、降血脂、抗肥胖和降胆固醇化合物，其衍生物、类似物、互变异构体、立体异构体、多晶形态、药学上可接受的盐、药学上可接受的溶剂化物以及含有它们的药学上可接受的组合物。

  公开号：

  US20030229083A1

文献信息

• Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
  申请人：DR. REDDY'S LABORATORIES LIMITED

  公开号：US20030229083A1

  公开（公告）日：2003-12-11

  The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula (I), 1 their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them.

  本发明涉及具有化学式（I）的新型抗糖尿病、降血脂、抗肥胖和降胆固醇化合物，其衍生物、类似物、互变异构体、立体异构体、多晶形态、药学上可接受的盐、药学上可接受的溶剂化物以及含有它们的药学上可接受的组合物。
• Basic salts and monohydrates of certain alpha, beta-propionic acid derivative
  申请人：Palle Venkata Raghavendra Charyulu

  公开号：US20050277693A1

  公开（公告）日：2005-12-15

  The invention provides novel salts of (S)-2-methoxy-3-[4-3-(4-methanesulfonyloxyphenyl)propylamino} phenyl] propionic acid, including Arginine salt of (S)-2-methoxy-3-[4-3-(4-methanesulfonyloxyphenyl)propylamino} phenyl] propionic acid monohydrate, Arginine salt of (S)-2-methoxy-3-[4-3-(4-methanesulfonyloxyphenyl) propylamino} phenyl] propionic acid, and (S)-2-methoxy-3-[4-3-(4-methanesulfonyloxyphenyl)propylamino} phenyl] propionic acid monohydrate. Various aspects and embodiments are included. Compositions containing novel salts of (S)-2-methoxy-3-[4-3-(4-methanesulfonyloxyphenyl) propylamino}phenyl] propionic acid are also provided.

  本发明提供了(S)-2-甲氧基-3-[4-3-(4-甲烷磺酰氧苯基)丙基氨基}苯基]丙酸的新型盐，包括(S)-2-甲氧基-3-[4-3-(4-甲烷磺酰氧苯基)丙基氨基}苯基]丙酸单水合物的精氨酸盐，(S)-2-甲氧基-3-[4-3-(4-甲烷磺酰氧苯基)丙基氨基}苯基]丙酸的精氨酸盐，以及(S)-2-甲氧基-3-[4-3-(4-甲烷磺酰氧苯基)丙基氨基}苯基]丙酸单水合物。包括各种方面和实施例。还提供了含有(S)-2-甲氧基-3-[4-3-(4-甲烷磺酰氧苯基)丙基氨基}苯基]丙酸新型盐的组合物。
• Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
  申请人：Debnath Bhunia

  公开号：US20070093476A1

  公开（公告）日：2007-04-26

  The present invention relates to novel compounds of formula (I) and their pharmaceutically acceptable salts, wherein ring “Ar 1 ” represents a monocyclic or polycyclic aromatic or partially saturated aromatic polycyclic, which may optionally contain up to 3 heteroatoms selected from N, S or O. The said monocyclic or polycyclic ring may be unsubstituted or have up to 4 substituents which may be identical or different; m and n independently represents an integer from 0 to 6; A represents O, S or bond; Y is selected from (CH 2 ) p′ (CH 2 ) p B(CH 2 ) q′ (CH 2 ) r B(CH 2 ) p D(CH 2 ) p′ where p, q and r each independently represents an integer from 0 to 6; B and D independently represents S, O, NR 4 or a bond, with a proviso that when B and D represents hereto atom p is not zero; R 4 represents hydrogen, alkyl, alkenyl, —S(O) 2 —R 8 or —C(O)R 8 where R 8 is alkyl, alkoxy; R 5 and R 6 independently represents hydrogen, alkyl, cycloalkyl or alkoxy; R 5 and R 6 together may form 3-8 membered cyclic ring which may optionally contains one or two hereto atoms selected from O, S or N; R 7 represents hydrogen, optionally substituted groups selected form alkyl, cycloalkyl, alkenyl or alkynyl. The present invention also relates to a process for preparation of compounds of formula (I), to pharmaceutical compositions containing compounds of formula (I) and their use in particular as antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic agents.

  本发明涉及公式（I）的新化合物及其药学上可接受的盐，其中环“Ar1”表示单环或多环芳香或部分饱和芳香多环，可选含有最多3个选自N、S或O的杂原子。所述的单环或多环环可以未取代或具有最多4个相同或不同的取代基；m和n分别表示0到6的整数；A表示O、S或键；Y选自（CH2）p′（CH2）pB（CH2）q′（CH2）rB（CH2）pD（CH2）p′，其中p、q和r各自独立地表示0到6的整数；B和D分别表示S、O、NR4或键，条件是当B和D表示杂原子时，p不为零；R4表示氢、烷基、烯基、—S（O）2—R8或—C（O）R8，其中R8为烷基、烷氧基；R5和R6各自独立地表示氢、烷基、环烷基或烷氧基；R5和R6可以一起形成3-8成员环，该环可以选择性地包含选自O、S或N的一个或两个杂原子；R7表示氢、可选地从烷基、环烷基、烯基或炔基中选择的取代基。本发明还涉及公式（I）化合物的制备方法，含有公式（I）化合物的制药组合物以及其作为抗糖尿病、降脂、抗肥胖和降胆固醇药物的应用。
• COMPOUNDS AND THEIR USE IN MEDICINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  申请人：Debnath Bhuniya

  公开号：US20070142470A1

  公开（公告）日：2007-06-21

  The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them.

  本发明涉及一种新型抗糖尿病、降脂、抗肥胖和降胆固醇的化合物，其化学式为(I)，其衍生物、类似物、互变异构体、立体异构体、多晶形态、药学上可接受的盐、药学上可接受的溶剂和含有它们的药学上可接受的组合物。
• Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
  申请人：Bhuniya Debnath

  公开号：US20110105748A1

  公开（公告）日：2011-05-05

  The present invention relates to novel propionic acid derivatives. More particularly, the present invention relates to beta-phenyl alpha-oxysubstituted propionic acids of the general formula (I). The present invention also relates to processes for the preparation of compounds of the formula (I) and their use in the preparation of compounds of formula (II).

  本发明涉及新型丙酸衍生物。更具体地，本发明涉及一般式（I）的β-苯基α-氧代取代丙酸。本发明还涉及制备式（I）化合物的方法及其在制备式（II）化合物中的应用。